Drug interactions for the following drug(s)

Interactions between your selected drugs

The metabolism of Oxycodone can be decreased when combined with Losartan.

The metabolism of Levothyroxine can be increased when combined with Acetaminophen.

The serum concentration of Phenytoin can be increased when it is combined with Acetaminophen.

The serum concentration of Phenytoin can be increased when it is combined with Acetylsalicylic acid.

The metabolism of Metoprolol can be increased when combined with Phenytoin.

The metabolism of Oxycodone can be decreased when combined with Metoprolol.

The serum concentration of Phenytoin can be increased when it is combined with Losartan.

Acetylsalicylic acid may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.

The serum concentration of Phenytoin can be increased when it is combined with Ascorbic acid.

The metabolism of Levothyroxine can be increased when combined with Acetaminophen.

The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Acetylsalicylic acid.

The serum concentration of Metoprolol can be increased when it is combined with Losartan.

The serum concentration of Phenytoin can be increased when it is combined with Acetaminophen.

The serum concentration of Phenytoin can be decreased when it is combined with Levothyroxine.

The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Oxycodone.

The metabolism of Metoprolol can be decreased when combined with Niacin.

The serum concentration of Metoprolol can be increased when it is combined with Acetaminophen.

The metabolism of Acetylsalicylic acid can be decreased when combined with Levothyroxine.

Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol.

The serum concentration of Metoprolol can be decreased when it is combined with Levothyroxine.

Folic Acid may decrease the excretion rate of Acetaminophen which could result in a higher serum level.

The metabolism of Levothyroxine can be decreased when combined with Losartan.

Folic Acid may decrease the excretion rate of Acetaminophen which could result in a higher serum level.

The serum concentration of Losartan can be increased when it is combined with Acetaminophen.

Ferrous bisglycinate can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.

The serum concentration of Ascorbic acid can be increased when it is combined with Losartan.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 979480, name = Losartan Potassium 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1049221, name = Acetaminophen 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to Oxycodone, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Oxycodone and Losartan. Drug1 is resolved to Acetaminophen, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Acetaminophen and Losartan.

Drug1 (rxcui = 209387, name = Acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 966201, name = Levothyroxine Sodium 0.15 MG Oral Tablet [Synthroid], tty = SBD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Acetaminophen and Levothyroxine.

Drug1 (rxcui = 1049221, name = Acetaminophen 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1313112, name = Phenytoin 25 MG/ML Oral Suspension, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to Phenytoin and interaction asserted in DrugBank between Acetaminophen and Phenytoin. Drug1 is resolved to Oxycodone, Drug2 is resolved to Phenytoin and interaction asserted in DrugBank between Oxycodone and Phenytoin.

Drug1 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1313112, name = Phenytoin 25 MG/ML Oral Suspension, tty = SCD). Drug1 is resolved to Aspirin, Drug2 is resolved to Phenytoin and interaction asserted in DrugBank between Acetylsalicylic acid and Phenytoin.

Drug1 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1313112, name = Phenytoin 25 MG/ML Oral Suspension, tty = SCD). Drug1 is resolved to Metoprolol, Drug2 is resolved to Phenytoin and interaction asserted in DrugBank between Metoprolol and Phenytoin.

Drug1 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1049221, name = Acetaminophen 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to Metoprolol, Drug2 is resolved to Oxycodone and interaction asserted in DrugBank between Metoprolol and Oxycodone. Drug1 is resolved to Acetaminophen, Drug2 is resolved to Metoprolol and interaction asserted in DrugBank between Acetaminophen and Metoprolol.

Drug1 (rxcui = 979480, name = Losartan Potassium 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1313112, name = Phenytoin 25 MG/ML Oral Suspension, tty = SCD). Drug1 is resolved to Phenytoin, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Phenytoin and Losartan.

Drug1 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1102196, name = Ascorbic Acid 100 MG / Biotin 0.3 MG / Calcium Pantothenate 0.3 MG / ferrous bisglycinate 65 MG / Folic Acid 1 MG / formic acid 155 MG / Iron-Dextran Complex 65 MG / Niacin 25 MG / Pyridoxine Hydrochloride 30 MG / Riboflavin 5 MG / Thiamine hydrochloride 5 MG / Vitamin B 12 0.01 MG Oral Tablet, tty = SCD). Drug1 is resolved to Aspirin, Drug2 is resolved to Vitamin B 12 and interaction asserted in DrugBank between Acetylsalicylic acid and Cyanocobalamin. Drug1 is resolved to Aspirin, Drug2 is resolved to Folic Acid and interaction asserted in DrugBank between Acetylsalicylic acid and Folic Acid. Drug1 is resolved to Aspirin, Drug2 is resolved to pantothenate and interaction asserted in DrugBank between Acetylsalicylic acid and Pantothenic acid. Drug1 is resolved to Aspirin, Drug2 is resolved to formic acid and interaction asserted in DrugBank between Acetylsalicylic acid and Formic Acid. Drug1 is resolved to Aspirin, Drug2 is resolved to pyridoxine and interaction asserted in DrugBank between Acetylsalicylic acid and Pyridoxine.

Drug1 (rxcui = 1102196, name = Ascorbic Acid 100 MG / Biotin 0.3 MG / Calcium Pantothenate 0.3 MG / ferrous bisglycinate 65 MG / Folic Acid 1 MG / formic acid 155 MG / Iron-Dextran Complex 65 MG / Niacin 25 MG / Pyridoxine Hydrochloride 30 MG / Riboflavin 5 MG / Thiamine hydrochloride 5 MG / Vitamin B 12 0.01 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1313112, name = Phenytoin 25 MG/ML Oral Suspension, tty = SCD). Drug1 is resolved to Ascorbic Acid, Drug2 is resolved to Phenytoin and interaction asserted in DrugBank between Ascorbic acid and Phenytoin. Drug1 is resolved to Folic Acid, Drug2 is resolved to Phenytoin and interaction asserted in DrugBank between Folic Acid and Phenytoin. Drug1 is resolved to Phenytoin, Drug2 is resolved to pyridoxine and interaction asserted in DrugBank between Phenytoin and Pyridoxine. Drug1 is resolved to Niacin, Drug2 is resolved to Phenytoin and interaction asserted in DrugBank between Niacin and Phenytoin.

Drug1 (rxcui = 966201, name = Levothyroxine Sodium 0.15 MG Oral Tablet [Synthroid], tty = SBD). Drug2 (rxcui = 1049221, name = Acetaminophen 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Acetaminophen and Levothyroxine. Drug1 is resolved to Oxycodone, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Oxycodone and Levothyroxine.

Drug1 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 979480, name = Losartan Potassium 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to Aspirin, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Acetylsalicylic acid and Losartan.

Drug1 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979480, name = Losartan Potassium 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to Metoprolol, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Metoprolol and Losartan.

Drug1 (rxcui = 209387, name = Acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 1313112, name = Phenytoin 25 MG/ML Oral Suspension, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to Phenytoin and interaction asserted in DrugBank between Acetaminophen and Phenytoin.

Drug1 (rxcui = 966201, name = Levothyroxine Sodium 0.15 MG Oral Tablet [Synthroid], tty = SBD). Drug2 (rxcui = 1313112, name = Phenytoin 25 MG/ML Oral Suspension, tty = SCD). Drug1 is resolved to Phenytoin, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Phenytoin and Levothyroxine.

Drug1 (rxcui = 876195, name = POLYETHYLENE GLYCOL 3350 17000 MG Powder for Oral Solution [Miralax], tty = SBD). Drug2 (rxcui = 1049221, name = Acetaminophen 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to Oxycodone, Drug2 is resolved to POLYETHYLENE GLYCOL 3350 and interaction asserted in DrugBank between Oxycodone and Polyethylene glycol.

Drug1 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1102196, name = Ascorbic Acid 100 MG / Biotin 0.3 MG / Calcium Pantothenate 0.3 MG / ferrous bisglycinate 65 MG / Folic Acid 1 MG / formic acid 155 MG / Iron-Dextran Complex 65 MG / Niacin 25 MG / Pyridoxine Hydrochloride 30 MG / Riboflavin 5 MG / Thiamine hydrochloride 5 MG / Vitamin B 12 0.01 MG Oral Tablet, tty = SCD). Drug1 is resolved to Metoprolol, Drug2 is resolved to Niacin and interaction asserted in DrugBank between Metoprolol and Niacin.

Drug1 (rxcui = 209387, name = Acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to Metoprolol and interaction asserted in DrugBank between Acetaminophen and Metoprolol.

Drug1 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 966201, name = Levothyroxine Sodium 0.15 MG Oral Tablet [Synthroid], tty = SBD). Drug1 is resolved to Aspirin, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Acetylsalicylic acid and Levothyroxine.

Drug1 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to Aspirin, Drug2 is resolved to Metoprolol and interaction asserted in DrugBank between Acetylsalicylic acid and Metoprolol.

Drug1 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966201, name = Levothyroxine Sodium 0.15 MG Oral Tablet [Synthroid], tty = SBD). Drug1 is resolved to Metoprolol, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Metoprolol and Levothyroxine.

Drug1 (rxcui = 1049221, name = Acetaminophen 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1102196, name = Ascorbic Acid 100 MG / Biotin 0.3 MG / Calcium Pantothenate 0.3 MG / ferrous bisglycinate 65 MG / Folic Acid 1 MG / formic acid 155 MG / Iron-Dextran Complex 65 MG / Niacin 25 MG / Pyridoxine Hydrochloride 30 MG / Riboflavin 5 MG / Thiamine hydrochloride 5 MG / Vitamin B 12 0.01 MG Oral Tablet, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to Folic Acid and interaction asserted in DrugBank between Acetaminophen and Folic Acid. Drug1 is resolved to Niacin, Drug2 is resolved to Oxycodone and interaction asserted in DrugBank between Niacin and Oxycodone. Drug1 is resolved to Folic Acid, Drug2 is resolved to Oxycodone and interaction asserted in DrugBank between Folic Acid and Oxycodone. Drug1 is resolved to Acetaminophen, Drug2 is resolved to pyridoxine and interaction asserted in DrugBank between Acetaminophen and Pyridoxine. Drug1 is resolved to Acetaminophen, Drug2 is resolved to Vitamin B 12 and interaction asserted in DrugBank between Acetaminophen and Cyanocobalamin. Drug1 is resolved to Acetaminophen, Drug2 is resolved to Niacin and interaction asserted in DrugBank between Acetaminophen and Niacin.

Drug1 (rxcui = 966201, name = Levothyroxine Sodium 0.15 MG Oral Tablet [Synthroid], tty = SBD). Drug2 (rxcui = 979480, name = Losartan Potassium 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Levothyroxine and Losartan.

Drug1 (rxcui = 209387, name = Acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 1102196, name = Ascorbic Acid 100 MG / Biotin 0.3 MG / Calcium Pantothenate 0.3 MG / ferrous bisglycinate 65 MG / Folic Acid 1 MG / formic acid 155 MG / Iron-Dextran Complex 65 MG / Niacin 25 MG / Pyridoxine Hydrochloride 30 MG / Riboflavin 5 MG / Thiamine hydrochloride 5 MG / Vitamin B 12 0.01 MG Oral Tablet, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to Folic Acid and interaction asserted in DrugBank between Acetaminophen and Folic Acid. Drug1 is resolved to Acetaminophen, Drug2 is resolved to pyridoxine and interaction asserted in DrugBank between Acetaminophen and Pyridoxine. Drug1 is resolved to Acetaminophen, Drug2 is resolved to Vitamin B 12 and interaction asserted in DrugBank between Acetaminophen and Cyanocobalamin. Drug1 is resolved to Acetaminophen, Drug2 is resolved to Niacin and interaction asserted in DrugBank between Acetaminophen and Niacin.

Drug1 (rxcui = 209387, name = Acetaminophen 325 MG Oral Tablet [Tylenol], tty = SBD). Drug2 (rxcui = 979480, name = Losartan Potassium 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Acetaminophen and Losartan.

Drug1 (rxcui = 966201, name = Levothyroxine Sodium 0.15 MG Oral Tablet [Synthroid], tty = SBD). Drug2 (rxcui = 1102196, name = Ascorbic Acid 100 MG / Biotin 0.3 MG / Calcium Pantothenate 0.3 MG / ferrous bisglycinate 65 MG / Folic Acid 1 MG / formic acid 155 MG / Iron-Dextran Complex 65 MG / Niacin 25 MG / Pyridoxine Hydrochloride 30 MG / Riboflavin 5 MG / Thiamine hydrochloride 5 MG / Vitamin B 12 0.01 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to ferrous bisglycinate and interaction asserted in DrugBank between Levothyroxine and Ferrous bisglycinate. Drug1 is resolved to Ascorbic Acid, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Ascorbic acid and Levothyroxine. Drug1 is resolved to Iron-Dextran Complex, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Iron Dextran and Levothyroxine.

Drug1 (rxcui = 979480, name = Losartan Potassium 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1102196, name = Ascorbic Acid 100 MG / Biotin 0.3 MG / Calcium Pantothenate 0.3 MG / ferrous bisglycinate 65 MG / Folic Acid 1 MG / formic acid 155 MG / Iron-Dextran Complex 65 MG / Niacin 25 MG / Pyridoxine Hydrochloride 30 MG / Riboflavin 5 MG / Thiamine hydrochloride 5 MG / Vitamin B 12 0.01 MG Oral Tablet, tty = SCD). Drug1 is resolved to Ascorbic Acid, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Ascorbic acid and Losartan.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.